Category archive

Pharmaceutical News - page 3

BIOCAD started working on mRNA vaccine against coronavirus
Pharmaceutical News

BIOCAD started working on mRNA vaccine against coronavirus

Biotechnological company BIOCAD has announced the research in order to create an mRNA vaccine against SARS-COV-2 (coronavirus). Development will be based on previous pipelines for mRNA-oncovaccines creation: an area where the company has a great expertise. The first animal studies are scheduled for the end of April. According to Dmitry Morozov, BIOCAD CEO, today the whole world is working on the search for coronavirus treatment: “By now, 66 companies around the world have announced the development of drugs against SARS-COV-19,… Keep Reading

Eisai: All-case Surveillance Condition for Approval of "Actonel 17.5 mg tablets" for Treatment of Paget's Disease of Bone Cleared in Japan
Pharmaceutical News

Eisai: All-case Surveillance Condition for Approval of “Actonel 17.5 mg tablets” for Treatment of Paget’s Disease of Bone Cleared in Japan

EA Pharma Co., Ltd. and its parent company Eisai Co., Ltd. announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has given notification of the results of reexamination to the effect that the “all-case surveillance” specified drug use-results survey condition required for the approval of “Actonel 17.5 mg tablets” (risedronate sodium hydrate) indicated for the treatment of Paget’s disease of bone has been lifted. In July 2008, MHLW approved the indication for treatment of “Paget’s disease of bone” for… Keep Reading

1 2 3 4 5 … 111
Go to Top